Agonistic anti-CD27 antibody ameliorates EAE by suppressing IL-17 production

Eur J Immunol. 2022 Oct;52(10):1620-1629. doi: 10.1002/eji.202149698. Epub 2022 Aug 15.

Abstract

CD27/CD70 costimulation enhances T-cell survival, memory formation and Th1-cell differentiation and effector function. In addition to promoting Th1 responses, CD27 signaling has been shown to exert a negative regulatory role on IL-17 production, resulting in increased sensitivity of CD27 KO mice to EAE. By inducing EAE in full CD27 KO mice, and in a novel, T-cell specific CD27 KO mouse strain (CD4-Cre x CD27flox/flox ), we demonstrate herein that CD27 engagement by its natural ligand (CD70) suppresses IL-17 production in a cell autonomous fashion. We further show that CD27 engagement by an agonistic antibody given after EAE induction or at symptom onset similarly suppresses IL-17 production by activated CD4+ T cells infiltrating the inflamed CNS while IFN-γ production was unaffected, leading to an amelioration of inflammatory-related symptoms. These findings propose CD27 costimulation as a potential candidate for therapeutic manipulation to treat autoimmune and autoinflammatory diseases characterized by excessive IL-17 production.

Keywords: CD27; EAE; Th17-cells; autoimmunity; costimulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CD27 Ligand*
  • Encephalomyelitis, Autoimmune, Experimental*
  • Interleukin-17
  • Ligands
  • Mice
  • Mice, Inbred C57BL
  • Th1 Cells
  • Tumor Necrosis Factor Receptor Superfamily, Member 7

Substances

  • CD27 Ligand
  • Interleukin-17
  • Ligands
  • Tumor Necrosis Factor Receptor Superfamily, Member 7